Last week, an FDA advisory committee met to vote on whether to recommend Americans receive a booster shot of the Johnson & Johnson vaccine. The FDA, which had to rely on data provided by the vaccine maker given that trial data had not been provided to the agency in time, decided to vote on recommending it despite the sample size of 17 people.
What. The. F&@k